01/10/2025
Mannose has been explored for its potential in cancer treatment, primarily due to its metabolic effects on tumor cells. Here is an overview based on recent research:
General Mechanism: Mannose is a sugar that can be taken up by cells using the same transporters as glucose. However, instead of being metabolized like glucose, mannose accumulates within cells as mannose-6-phosphate, which can inhibit glycolysis and other metabolic pathways crucial for tumor growth. This metabolic disruption can lead to growth retardation of cancer cells and enhance their sensitivity to chemotherapy.
Cancer Types: Studies have shown that mannose can affect various cancer types in vitro and in vivo. For instance, it has shown potential in slowing tumor growth in mouse models of pancreatic, lung, and skin cancers. Mannose has also been investigated for its effects on non-small cell lung cancer (NSCLC), where it was found to suppress proliferation and metastasis by targeting the ERK/GSK-3β/β-catenin/SNAIL axis.
Combination with Chemotherapy: One of the key findings from research is that mannose can enhance the effectiveness of chemotherapeutic agents like cisplatin and doxorubicin. This is thought to occur because mannose reduces the levels of anti-apoptotic proteins, making cancer cells more susceptible to chemotherapy-induced cell death.
Phosphomannose Isomerase (PMI): The sensitivity of cancer cells to mannose is inversely related to the levels of PMI. Cells with low PMI levels are more sensitive to mannose treatment due to the accumulation of mannose-6-phosphate, which disrupts glucose metabolism. This suggests that PMI levels could serve as a biomarker for predicting which patients might benefit from mannose therapy.
Safety and Clinical Use: While promising in preclinical studies, mannose has not yet been approved for clinical use in cancer treatment. There's a caution against self-prescribing mannose for cancer due to potential side effects and the need for more human studies. Researchers emphasize the importance of consulting with healthcare providers before using mannose supplements for cancer.
Current Research Status: The research is still at an early stage, with much of the evidence coming from animal models or in vitro studies. The next steps include investigating which cancer cell lines are most responsive to mannose and expanding these studies to human trials to establish efficacy, safety, and optimal dosing in humans.
In summary, while mannose shows potential as an adjunct in cancer therapy by impairing tumor metabolism and enhancing chemotherapy, it is not yet ready for clinical application. Research continues to explore its full potential, focusing on its mechanisms of action and identifying patient subgroups who might benefit the most.
